期刊
EUROPEAN JOURNAL OF IMMUNOLOGY
卷 46, 期 5, 页码 1091-1100出版社
WILEY
DOI: 10.1002/eji.201545780
关键词
Cytokines; Immune regulation; Innate immunity; Interleukin-33
类别
资金
- Science Foundation Ireland (SFI)
- National Children's Research Centre
- SFI [12/IA/1421]
- SFI Research Centre, Advanced Materials and BioEngineering Research (AMBER) [SFI/12/RC/2278]
Interleukin (IL)-33, a member of the IL-1 family, was originally described in 2005 as a potent initiator of type 2 immunity found during allergic inflammation and parasitic infections. IL-33 has been shown to play important and potent roles bridging innate and adaptive immunity in the regulation of tissue homeostasis, injury, and repair. Recent discoveries have extended the range of functions for IL-33 beyond type 2 conditions and its role as an alarmin at barrier sites, with emerging central roles for IL-33 in T-cell regulation, obesity, viral and tumor immunity. Here, we review the recent advances on how IL-33 activity is regulated, its immunomodulatory properties on innate and adaptive cells, and the newly discovered roles of IL-33 in obesity, intestinal inflammation, and tumorigenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据